01 November 2004
Transgenic animals in medicine: Integration and expression of foreign genes, theoretical and applied aspects
Igor L. Goldman, Sergei G. Kadulin, Sergei V. RazinMed Sci Monit 2004; 10(11): RA274-285 :: ID: 11820
Abstract
The production of different pharmaceutically important human proteins in the mammary gland of transgenic animals constitutes an important field of modern biotechnology. In addition, transgenic animals are used to develop suitable models of various human diseases and the possibility of using transgenic technologies to adapt pigs for xenotransplantation of their organs to humans is widely discussed. All these practical applications depend on the availability of reliable techniques to obtain transgenic animals with the necessary spectrum of transgene(s) expression. In the present review we discuss different aspects of producing transgenic animals by microinjection procedure, including both technical aspects and theoretical issues. As far as the technical aspects are concerned, special emphasis is placed on DNA preparation, microinjection timing, vectors permitting delivery of large genomic fragments, and approaches used to increase integration frequency. The molecular basis of the advantage of transgene microinjection into a male pronucleus is discussed. Finally, different strategies used to obtain polytransgenic animals are critically reviewed. In the section devoted to theoretical issues, the mechanisms of integration and molecular systems regulating transgene expression are extensively discussed. In particular, the importance of the domain-level regulatory systems is outlined and experimental approaches permitting the use of the domain-level regulatory systems of the genes encoding milk proteins are described and discussed.
Keywords: Animals, Genetically Modified - genetics, Animals, Genetically Modified - genetics, Biomedical Research, Biotechnology, Cloning, Molecular, Gene Expression - genetics, Models, Genetic, Transgenes - genetics
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952